<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Health Medical Pharma &#8211; РИСК-АКАДЕМИЯ &#8211; АНО ДПО ИСАР</title>
	<atom:link href="https://risk-academy.ru/tag/health-medical-pharma/feed/" rel="self" type="application/rss+xml" />
	<link>https://risk-academy.ru</link>
	<description>Управление рисками, риск менеджмент, обучение по управлению рисками, тренинг риск менеджмент</description>
	<lastBuildDate>Wed, 02 Dec 2020 14:39:34 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://raruswebsite.s3.amazonaws.com/wp-content/uploads/2018/02/10213225/cropped-favicon-32x32.png</url>
	<title>Health Medical Pharma &#8211; РИСК-АКАДЕМИЯ &#8211; АНО ДПО ИСАР</title>
	<link>https://risk-academy.ru</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Financial and Reputational Loss: A Price Too High</title>
		<link>https://risk-academy.ru/financial-and-reputational-loss-a-price-too-high/</link>
		
		<dc:creator><![CDATA[riskacademy]]></dc:creator>
		<pubDate>Wed, 02 Dec 2020 12:00:20 +0000</pubDate>
				<category><![CDATA[Блоги на английском]]></category>
		<category><![CDATA[Иностранные блоги]]></category>
		<category><![CDATA[Reputational risk]]></category>
		<category><![CDATA[Price Too High ForteBank]]></category>
		<category><![CDATA[Non-financial risk]]></category>
		<category><![CDATA[Financial law]]></category>
		<category><![CDATA[Business Finance]]></category>
		<category><![CDATA[Health Medical Pharma]]></category>
		<category><![CDATA[Financial risk]]></category>
		<category><![CDATA[Economy]]></category>
		<category><![CDATA[Financial markets]]></category>
		<guid isPermaLink="false">https://risk-academy.ru/financial-and-reputational-loss-a-price-too-high/</guid>

					<description><![CDATA[ForteBank CCO Timur Mussin continues a discussion on the real cost of noncompliance with a look at the various penalties – reputational, financial and otherwise – associated with regulatory violations. [&#8230;]]]></description>
										<content:encoded><![CDATA[<div>
                </p>
<div class="intro-text">
<p><em>ForteBank CCO Timur Mussin continues a discussion on the real cost of noncompliance with a look at the various penalties – reputational, financial and otherwise – associated with regulatory violations.</em></p>
</div>
<p><em>Read Part 1 here.</em></p>
<h2>High-Risk Products</h2>
<p>As part of fierce competition, organizations are improving their products and services, including through innovative solutions. At the same time, without considering the compliance and money laundering risks associated with these decisions, it is highly likely that the organization may encounter problems caused by insufficient elaboration of a new product or service, which in turn will entail sanctions by the regulator or complaints and lawsuits by clients.</p>
<p>An innovative product can bring significant profit to an organization, which can exceed the size of potential fines, but it can also deprive the organization of a license and the ability to continue to work in the market if certain regulations aren’t followed during its production.</p>
<p>For example, the risks of trading cryptocurrency are mainly related to its volatility and anonymity. They are high risk and speculative, and it is important that you understand the risks before you start working with it. By the way, crimes associated with cryptocurrency accounted for more than $4 billion in&#8230;</p>
</div>
<p><a href="http://feedproxy.google.com/~r/CorporateComplianceInsights/~3/J_ELIkyRyTA/">Подробнее&#8230;</a></p>
<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
<!-- RA -->
<ins class="adsbygoogle"
     style="display:inline-block;width:728px;height:90px"
     data-ad-client="ca-pub-6192158489792937"
     data-ad-slot="6411604661"></ins>
<script>
     (adsbygoogle = window.adsbygoogle || []).push({});
</script>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Surge in cyber attacks on Indian vaccine makers in Oct-Nov: Report &#8211; ETCIO.com</title>
		<link>https://risk-academy.ru/surge-in-cyber-attacks-on-indian-vaccine-makers-in-oct-nov-report-etcio-com/</link>
		
		<dc:creator><![CDATA[riskacademy]]></dc:creator>
		<pubDate>Sat, 28 Nov 2020 11:33:33 +0000</pubDate>
				<category><![CDATA[Cyber Risks]]></category>
		<category><![CDATA[Cyberattack]]></category>
		<category><![CDATA[Politics]]></category>
		<category><![CDATA[crime]]></category>
		<category><![CDATA[Health Medical Pharma]]></category>
		<category><![CDATA[Technology Internet]]></category>
		<category><![CDATA[Computer security]]></category>
		<category><![CDATA[Cybercrime]]></category>
		<guid isPermaLink="false">https://risk-academy.ru/surge-in-cyber-attacks-on-indian-vaccine-makers-in-oct-nov-report-etcio-com/</guid>

					<description><![CDATA[Surge in cyber attacks on Indian vaccine makers in Oct-Nov: Report&#160;&#160;ETCIO.com Read More&#8230;]]></description>
										<content:encoded><![CDATA[<p>Surge in cyber attacks on Indian vaccine makers in Oct-Nov: Report&nbsp;&nbsp;<font color="#6f6f6f">ETCIO.com</font></p>
<p><a href="https://cio.economictimes.indiatimes.com/news/digital-security/surge-in-cyber-attacks-on-indian-vaccine-makers-in-oct-nov-report/79458444">Read More&#8230;</a></p>
<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
<!-- RA -->
<ins class="adsbygoogle"
     style="display:inline-block;width:728px;height:90px"
     data-ad-client="ca-pub-6192158489792937"
     data-ad-slot="6411604661"></ins>
<script>
     (adsbygoogle = window.adsbygoogle || []).push({});
</script>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Cyturus Technologies Announces The Launch Of New Website And Branding Campaign</title>
		<link>https://risk-academy.ru/cyturus-technologies-announces-the-launch-of-new-website-and-branding-campaign/</link>
		
		<dc:creator><![CDATA[riskacademy]]></dc:creator>
		<pubDate>Tue, 24 Nov 2020 07:09:38 +0000</pubDate>
				<category><![CDATA[Cyber Risks]]></category>
		<category><![CDATA[Technology Internet]]></category>
		<category><![CDATA[FREMONT]]></category>
		<category><![CDATA[Cyturus]]></category>
		<category><![CDATA[T-Mobile Polska]]></category>
		<category><![CDATA[Passion Made Possible]]></category>
		<category><![CDATA[risk management]]></category>
		<category><![CDATA[Business Finance]]></category>
		<category><![CDATA[Health Medical Pharma]]></category>
		<category><![CDATA[Executive]]></category>
		<guid isPermaLink="false">https://risk-academy.ru/cyturus-technologies-announces-the-launch-of-new-website-and-branding-campaign/</guid>

					<description><![CDATA[The new branding and website from Cyturus highlight its unique Adaptive Risk Model (ARM), including its greatly expanded platform capabilities and features. In addition, Cyturus is also promoting The Cyber [&#8230;]]]></description>
										<content:encoded><![CDATA[<div id="desc_part">
<p><strong>The new branding and website from Cyturus highlight its unique Adaptive Risk Model (ARM), including its greatly expanded platform capabilities and features. In addition, Cyturus is also promoting The Cyber Risk Tracker (CRT), which enables users to continuously manage cyber risk while providing visibility to the executive suite.</strong></p>
<p><strong>Fremont, CA:</strong> Cyturus, a top-rated risk assessment firm, has partnered with Cyber Theory, a full- service cybersecurity marketing advisory firm, so as to introduce its bleeding-edge risk management platform to IT professionals tasked with managing cyber risk as well as keeping their organizations safe. Cyber Theory offers deep marketing expertise in the world of cybersecurity, providing a network of relationships encompassing all aspects of cybersecurity, in addition to the related fields of fraud, compliance, audit, and risk management.</p>
<p>The new branding and website from Cyturus highlight its unique Adaptive Risk Model (ARM), including its greatly expanded platform capabilities and features. In addition, Cyturus is also promoting The Cyber Risk Tracker (CRT), which enables users to continuously manage cyber risk while providing visibility to the&#8230;</p>
</div>
<p><a href="https://www.cioapplications.com/news/cyturus-technologies-announces-the-launch-of-new-website-and-branding-campaign--nid-6856.html">Read More&#8230;</a></p>
<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
<!-- RA -->
<ins class="adsbygoogle"
     style="display:inline-block;width:728px;height:90px"
     data-ad-client="ca-pub-6192158489792937"
     data-ad-slot="6411604661"></ins>
<script>
     (adsbygoogle = window.adsbygoogle || []).push({});
</script>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>How to Safely Restart Elective Surgeries After a Covid Spike</title>
		<link>https://risk-academy.ru/how-to-safely-restart-elective-surgeries-after-a-covid-spike/</link>
		
		<dc:creator><![CDATA[riskacademy]]></dc:creator>
		<pubDate>Thu, 19 Nov 2020 16:36:09 +0000</pubDate>
				<category><![CDATA[HBR]]></category>
		<category><![CDATA[health systems]]></category>
		<category><![CDATA[Elective Surgery]]></category>
		<category><![CDATA[health care systems]]></category>
		<category><![CDATA[Surgery]]></category>
		<category><![CDATA[Medical terminology]]></category>
		<category><![CDATA[B.C.'s Response to COVID-19]]></category>
		<category><![CDATA[Health Medical Pharma]]></category>
		<category><![CDATA[Executive]]></category>
		<guid isPermaLink="false">https://risk-academy.ru/how-to-safely-restart-elective-surgeries-after-a-covid-spike/</guid>

					<description><![CDATA[Executive Summary The pandemic has wreaked havoc with health care systems’ surgical staffs. Some clinicians are fatigued and stressed, and many are out of practice. They are having to contend [&#8230;]]]></description>
										<content:encoded><![CDATA[<div>
<h4 class="text-gray-light mbn mt-large2">Executive Summary</h4>
<p>The pandemic has wreaked havoc with health care systems’ surgical staffs. Some clinicians are fatigued and stressed, and many are out of practice. They are having to contend with large backlogs of procedures that were postponed. And they have to contend with the ongoing pandemic, with all its uncertainties. To keep surgical staffs and patients safe during these difficult times, health systems should take four steps: make risk visible; ensure that staffs are abiding by existing procedures and protocols and adopting new ones when the need arises; double down&#8230;</p>
</div>
<p><a href="http://feeds.hbr.org/~r/harvardbusiness/~3/TFotBR8xoMM/how-to-safely-restart-elective-surgeries-after-a-covid-spike">Read More&#8230;</a></p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Understanding the Enduring Consequences of Covid-19</title>
		<link>https://risk-academy.ru/understanding-the-enduring-consequences-of-covid-19/</link>
		
		<dc:creator><![CDATA[riskacademy]]></dc:creator>
		<pubDate>Mon, 09 Nov 2020 20:42:14 +0000</pubDate>
				<category><![CDATA[HBR]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Azeem Azhar]]></category>
		<category><![CDATA[Yale]]></category>
		<category><![CDATA[Infectious diseases]]></category>
		<category><![CDATA[COVID-19 pandemic]]></category>
		<category><![CDATA[Professor of Social]]></category>
		<category><![CDATA[Nicholas Christakis]]></category>
		<category><![CDATA[Articles]]></category>
		<category><![CDATA[Health Medical Pharma]]></category>
		<guid isPermaLink="false">https://risk-academy.ru/understanding-the-enduring-consequences-of-covid-19/</guid>

					<description><![CDATA[November 09, 2020 Azeem Azhar speaks with Yale Professor of Social and Natural Science, Internal Medicine &#38; Biomedical Engineering, Nicholas Christakis, whose latest book “Apollo’s Arrow,” lays out the three [&#8230;]]]></description>
										<content:encoded><![CDATA[<div>
<section id="details-section" class="podcast-tabs__section podcast-tabs__section--active" role="tabpanel">
    <span class="podcast-details__date publication-date text-gray">November 09, 2020</span><br />
    <!-- rename hbraudio class for default audio-player component to ignore it and hide this element --></p>
<p><strong>Azeem Azhar</strong> speaks with Yale Professor of Social and Natural Science, Internal Medicine &amp; Biomedical Engineering, <strong>Nicholas Christakis</strong>, whose latest book “Apollo’s Arrow,” lays out the three phases of the world’s recovery from the Covid-19 pandemic. Christakis argues that each phase will be fraught with risk and will leave an enduring impact on our society, economy, and politics.</p>
<p>They also discuss:</p>
<ul>
<li>How a successful vaccine will influence global geopolitics as a soft power.</li>
<li>How to deal with the pandemic on individual and community&#8230;</li>
</ul>
</section>
</div>
<p><a href="http://feeds.hbr.org/~r/harvardbusiness/~3/oLKw42DWWd0/understanding-the-enduring-consequences-of-covid-19">Read More&#8230;</a></p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Banks fold climate, pandemic and cyber risks into CCAR</title>
		<link>https://risk-academy.ru/banks-fold-climate-pandemic-and-cyber-risks-into-ccar/</link>
		
		<dc:creator><![CDATA[riskacademy]]></dc:creator>
		<pubDate>Sun, 01 Nov 2020 16:56:24 +0000</pubDate>
				<category><![CDATA[Cyber Risks]]></category>
		<category><![CDATA[Business Finance]]></category>
		<category><![CDATA[Health Medical Pharma]]></category>
		<category><![CDATA[http://subscriptions.risk.net/subscribe]]></category>
		<category><![CDATA[CCAR]]></category>
		<guid isPermaLink="false">https://risk-academy.ru/banks-fold-climate-pandemic-and-cyber-risks-into-ccar/</guid>

					<description><![CDATA[Banks have long faced an uphill task to accurately gauge the financial risks posed by climate change, pandemics and cyber attacks, and to put a dollar value on them for [&#8230;]]]></description>
										<content:encoded><![CDATA[<div>
<p>Banks have long faced an uphill task to accurately gauge the financial risks posed by climate change, pandemics and cyber attacks, and to put a dollar value on them for the purpose of capital planning. But while such risks have previously been treated as tail events, the coronavirus has made clear they can significantly affect the losses firms have to project as part of regulatory-mandated stress-testing.</p>
<p>“We’ve incorporated a lot of these risks into our scenarios from a CCAR [Comprehensive</p>
</div>
<div>
<div id="trial_print_message">
<p>Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content. </p>
<p>To access these options, along with all other subscription benefits, please contact <span class="__cf_email__" data-cfemail="dcb5b2bab39caeb5afb7f2b2b9a8">[email protected]</span> or view our subscription options here: http://subscriptions.risk.net/subscribe</p>
</div>
<div id="print_blocked_message">
<p>You are currently unable to print this content. Please contact <span class="__cf_email__" data-cfemail="fc95929a93bc8e958f97d2929988">[email protected]</span> to find out more.</p>
</div>
<div id="copy_blocked_message">
<p>You are currently unable to copy this content. Please contact <span class="__cf_email__" data-cfemail="97fef9f1f8d7e5fee4fcb9f9f2e3">[email protected]</span> to find out more.</p>
</div></div>
<p><a href="https://www.risk.net/risk-management/7704271/banks-fold-climate-pandemic-and-cyber-risks-into-ccar">Read More&#8230;</a></p>
<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
<!-- RA -->
<ins class="adsbygoogle"
     style="display:inline-block;width:728px;height:90px"
     data-ad-client="ca-pub-6192158489792937"
     data-ad-slot="6411604661"></ins>
<script>
     (adsbygoogle = window.adsbygoogle || []).push({});
</script>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Going Back to the Office</title>
		<link>https://risk-academy.ru/going-back-to-the-office/</link>
		
		<dc:creator><![CDATA[riskacademy]]></dc:creator>
		<pubDate>Mon, 26 Oct 2020 20:18:15 +0000</pubDate>
				<category><![CDATA[HBR]]></category>
		<category><![CDATA[Office Ladies]]></category>
		<category><![CDATA[The Office]]></category>
		<category><![CDATA[No Going Back]]></category>
		<category><![CDATA[Health Medical Pharma]]></category>
		<category><![CDATA[Emily]]></category>
		<category><![CDATA[Amy B.]]></category>
		<category><![CDATA[Earwolf]]></category>
		<guid isPermaLink="false">https://risk-academy.ru/going-back-to-the-office/</guid>

					<description><![CDATA[October 26, 2020 If working from home intensified the invisible labor women do and put even more pressure on us professionally and personally, what should we expect from life split [&#8230;]]]></description>
										<content:encoded><![CDATA[<div>
<section id="details-section" class="podcast-tabs__section podcast-tabs__section--active" role="tabpanel">
    <span class="podcast-details__date publication-date text-gray">October 26, 2020</span><br />
    <!-- rename hbraudio class for default audio-player component to ignore it and hide this element --></p>
<p>If working from home intensified the invisible labor women do and put even more pressure on us professionally and personally, what should we expect from life split between home and office? And without much of the interaction and amenities that being in an office used to offer us, is going in worth the trouble of wearing a mask all day, navigating the new rules, and taking the potential health risk? And what about those of us who can’t go back?</p>
<p>Women who’ve returned to their workplaces describe what it’s like to be back. Emily and Amy B&#8230;</p>
</section>
</div>
<p><a href="http://feeds.hbr.org/~r/harvardbusiness/~3/PDHGeUZ-OOM/going-back-to-the-office">Read More&#8230;</a></p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>How To Use Data To Build A Risk Narrative That Resonates With Executive Management &#8211; Danny Wong</title>
		<link>https://risk-academy.ru/how-to-use-data-to-build-a-risk-narrative-that-resonates-with-executive-management-danny-wong-2/</link>
		
		<dc:creator><![CDATA[riskacademy]]></dc:creator>
		<pubDate>Fri, 23 Oct 2020 20:00:09 +0000</pubDate>
				<category><![CDATA[Официальная группа ИСАР]]></category>
		<category><![CDATA[Technology Internet]]></category>
		<category><![CDATA[Human Interest]]></category>
		<category><![CDATA[Environment]]></category>
		<category><![CDATA[Danny Wong]]></category>
		<category><![CDATA[risk]]></category>
		<category><![CDATA[Executive Management]]></category>
		<category><![CDATA[Wong]]></category>
		<category><![CDATA[riskmanagement]]></category>
		<category><![CDATA[StrategicRisk]]></category>
		<category><![CDATA[ChangingRisk]]></category>
		<category><![CDATA[Business Finance]]></category>
		<category><![CDATA[Health Medical Pharma]]></category>
		<guid isPermaLink="false">https://risk-academy.ru/how-to-use-data-to-build-a-risk-narrative-that-resonates-with-executive-management-danny-wong-2/</guid>

					<description><![CDATA[How To Use Data To Build A Risk Narrative That Resonates With Executive Management &#8211; Danny Wong #risk, #riskmanagement, #strategicrisk, #changingrisk How To Use Data To Build A Risk Narrative [&#8230;]]]></description>
										<content:encoded><![CDATA[<p><span></p>
<p>How To Use Data To Build A Risk Narrative That Resonates With Executive Management &#8211; Danny Wong <a class="cp cq" href="https://facebook.com/hashtag/risk?refid=18&amp;_ft_=qid.6886914949668062957%3Amf_story_key.1225586537816278%3Agroup_id.412510262457247%3Atop_level_post_id.1225586537816278%3Atl_objid.1225586537816278%3Acontent_owner_id_new.608777141%3Apage_id.412510262457247%3Asrc.22%3Astory_location.6%3Astory_attachment_style.share%3Afilter.GroupStoriesByActivityEntQuery%3Atds_flgs.3%3Aott.AX--DBodT6bg96d3%3Apage_insights.%7B%22412510262457247%22%3A%7B%22page_id%22%3A412510262457247%2C%22page_id_type%22%3A%22group%22%2C%22actor_id%22%3A608777141%2C%22dm%22%3A%7B%22isShare%22%3A1%2C%22originalPostOwnerID%22%3A0%7D%2C%22psn%22%3A%22EntGroupMallPostCreationStory%22%2C%22post_context%22%3A%7B%22object_fbtype%22%3A657%2C%22publish_time%22%3A1603483209%2C%22story_name%22%3A%22EntGroupMallPostCreationStory%22%2C%22story_fbid%22%3A%5B1225586537816278%5D%7D%2C%22role%22%3A1%2C%22sl%22%3A6%7D%7D&amp;__tn__=%2As-R"><span class="cr cs">#risk</span></a>, <a class="cp cq" href="https://facebook.com/hashtag/riskmanagement?refid=18&amp;_ft_=qid.6886914949668062957%3Amf_story_key.1225586537816278%3Agroup_id.412510262457247%3Atop_level_post_id.1225586537816278%3Atl_objid.1225586537816278%3Acontent_owner_id_new.608777141%3Apage_id.412510262457247%3Asrc.22%3Astory_location.6%3Astory_attachment_style.share%3Afilter.GroupStoriesByActivityEntQuery%3Atds_flgs.3%3Aott.AX--DBodT6bg96d3%3Apage_insights.%7B%22412510262457247%22%3A%7B%22page_id%22%3A412510262457247%2C%22page_id_type%22%3A%22group%22%2C%22actor_id%22%3A608777141%2C%22dm%22%3A%7B%22isShare%22%3A1%2C%22originalPostOwnerID%22%3A0%7D%2C%22psn%22%3A%22EntGroupMallPostCreationStory%22%2C%22post_context%22%3A%7B%22object_fbtype%22%3A657%2C%22publish_time%22%3A1603483209%2C%22story_name%22%3A%22EntGroupMallPostCreationStory%22%2C%22story_fbid%22%3A%5B1225586537816278%5D%7D%2C%22role%22%3A1%2C%22sl%22%3A6%7D%7D&amp;__tn__=%2As-R"><span class="cr cs">#riskmanagement</span></a>, <a class="cp cq" href="https://facebook.com/hashtag/strategicrisk?refid=18&amp;_ft_=qid.6886914949668062957%3Amf_story_key.1225586537816278%3Agroup_id.412510262457247%3Atop_level_post_id.1225586537816278%3Atl_objid.1225586537816278%3Acontent_owner_id_new.608777141%3Apage_id.412510262457247%3Asrc.22%3Astory_location.6%3Astory_attachment_style.share%3Afilter.GroupStoriesByActivityEntQuery%3Atds_flgs.3%3Aott.AX--DBodT6bg96d3%3Apage_insights.%7B%22412510262457247%22%3A%7B%22page_id%22%3A412510262457247%2C%22page_id_type%22%3A%22group%22%2C%22actor_id%22%3A608777141%2C%22dm%22%3A%7B%22isShare%22%3A1%2C%22originalPostOwnerID%22%3A0%7D%2C%22psn%22%3A%22EntGroupMallPostCreationStory%22%2C%22post_context%22%3A%7B%22object_fbtype%22%3A657%2C%22publish_time%22%3A1603483209%2C%22story_name%22%3A%22EntGroupMallPostCreationStory%22%2C%22story_fbid%22%3A%5B1225586537816278%5D%7D%2C%22role%22%3A1%2C%22sl%22%3A6%7D%7D&amp;__tn__=%2As-R"><span class="cr cs">#strategicrisk</span></a>, <a class="cp cq" href="https://facebook.com/hashtag/changingrisk?refid=18&amp;_ft_=qid.6886914949668062957%3Amf_story_key.1225586537816278%3Agroup_id.412510262457247%3Atop_level_post_id.1225586537816278%3Atl_objid.1225586537816278%3Acontent_owner_id_new.608777141%3Apage_id.412510262457247%3Asrc.22%3Astory_location.6%3Astory_attachment_style.share%3Afilter.GroupStoriesByActivityEntQuery%3Atds_flgs.3%3Aott.AX--DBodT6bg96d3%3Apage_insights.%7B%22412510262457247%22%3A%7B%22page_id%22%3A412510262457247%2C%22page_id_type%22%3A%22group%22%2C%22actor_id%22%3A608777141%2C%22dm%22%3A%7B%22isShare%22%3A1%2C%22originalPostOwnerID%22%3A0%7D%2C%22psn%22%3A%22EntGroupMallPostCreationStory%22%2C%22post_context%22%3A%7B%22object_fbtype%22%3A657%2C%22publish_time%22%3A1603483209%2C%22story_name%22%3A%22EntGroupMallPostCreationStory%22%2C%22story_fbid%22%3A%5B1225586537816278%5D%7D%2C%22role%22%3A1%2C%22sl%22%3A6%7D%7D&amp;__tn__=%2As-R"><span class="cr cs">#changingrisk</span></a></p>
<p></span>
</p>
<p><a href="https://buff.ly/2SeeWgc"><img decoding="async" title="Business Finance" alt="Business Finance" src="https://i.ytimg.com/vi/TSVW8PJdSpg/hqdefault.jpg" width="112" height="112" class="l" role="presentation"></a> </p>
<p><a href="https://buff.ly/2SeeWgc">How To Use Data To Build A Risk Narrative That Resonates With Executive Management &#8211; Danny Wong</a></p>
<p><a href="https://www.facebook.com/groups/412510262457247/permalink/1225586537816278">Присоеденяйтесь к официальной группе ИСАР в Facebook</a> </p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Covid-19: How are CROs currently navigating through this difficult time?</title>
		<link>https://risk-academy.ru/covid-19-how-are-cros-currently-navigating-through-this-difficult-time/</link>
		
		<dc:creator><![CDATA[riskacademy]]></dc:creator>
		<pubDate>Fri, 23 Oct 2020 10:30:12 +0000</pubDate>
				<category><![CDATA[Официальная группа ИСАР]]></category>
		<category><![CDATA[Cros]]></category>
		<category><![CDATA[Outsourced Trading]]></category>
		<category><![CDATA[Harvey du Cros]]></category>
		<category><![CDATA[risk]]></category>
		<category><![CDATA[riskmanagement]]></category>
		<category><![CDATA[riskminds]]></category>
		<category><![CDATA[Health Medical Pharma]]></category>
		<guid isPermaLink="false">https://risk-academy.ru/covid-19-how-are-cros-currently-navigating-through-this-difficult-time/</guid>

					<description><![CDATA[Covid-19: How are CROs currently navigating through this difficult time? #risk, #riskmanagement, #riskminds Covid-19: How are CROs currently navigating through this difficult time? Присоеденяйтесь к официальной группе ИСАР в Facebook]]></description>
										<content:encoded><![CDATA[<p><span></p>
<p>Covid-19: How are CROs currently navigating through this difficult time? <a class="cp cq" href="https://facebook.com/hashtag/risk?refid=18&amp;_ft_=qid.6886773345331668504%3Amf_story_key.1225206621187603%3Agroup_id.412510262457247%3Atop_level_post_id.1225206621187603%3Atl_objid.1225206621187603%3Acontent_owner_id_new.608777141%3Apage_id.412510262457247%3Asrc.22%3Astory_location.6%3Astory_attachment_style.share%3Afilter.GroupStoriesByActivityEntQuery%3Atds_flgs.3%3Aott.AX_Y92KJ5Iont7jy%3Apage_insights.%7B%22412510262457247%22%3A%7B%22page_id%22%3A412510262457247%2C%22page_id_type%22%3A%22group%22%2C%22actor_id%22%3A608777141%2C%22dm%22%3A%7B%22isShare%22%3A1%2C%22originalPostOwnerID%22%3A0%7D%2C%22psn%22%3A%22EntGroupMallPostCreationStory%22%2C%22post_context%22%3A%7B%22object_fbtype%22%3A657%2C%22publish_time%22%3A1603449012%2C%22story_name%22%3A%22EntGroupMallPostCreationStory%22%2C%22story_fbid%22%3A%5B1225206621187603%5D%7D%2C%22role%22%3A1%2C%22sl%22%3A6%7D%7D&amp;__tn__=%2As-R"><span class="cr cs">#risk</span></a>, <a class="cp cq" href="https://facebook.com/hashtag/riskmanagement?refid=18&amp;_ft_=qid.6886773345331668504%3Amf_story_key.1225206621187603%3Agroup_id.412510262457247%3Atop_level_post_id.1225206621187603%3Atl_objid.1225206621187603%3Acontent_owner_id_new.608777141%3Apage_id.412510262457247%3Asrc.22%3Astory_location.6%3Astory_attachment_style.share%3Afilter.GroupStoriesByActivityEntQuery%3Atds_flgs.3%3Aott.AX_Y92KJ5Iont7jy%3Apage_insights.%7B%22412510262457247%22%3A%7B%22page_id%22%3A412510262457247%2C%22page_id_type%22%3A%22group%22%2C%22actor_id%22%3A608777141%2C%22dm%22%3A%7B%22isShare%22%3A1%2C%22originalPostOwnerID%22%3A0%7D%2C%22psn%22%3A%22EntGroupMallPostCreationStory%22%2C%22post_context%22%3A%7B%22object_fbtype%22%3A657%2C%22publish_time%22%3A1603449012%2C%22story_name%22%3A%22EntGroupMallPostCreationStory%22%2C%22story_fbid%22%3A%5B1225206621187603%5D%7D%2C%22role%22%3A1%2C%22sl%22%3A6%7D%7D&amp;__tn__=%2As-R"><span class="cr cs">#riskmanagement</span></a>, <a class="cp cq" href="https://facebook.com/hashtag/riskminds?refid=18&amp;_ft_=qid.6886773345331668504%3Amf_story_key.1225206621187603%3Agroup_id.412510262457247%3Atop_level_post_id.1225206621187603%3Atl_objid.1225206621187603%3Acontent_owner_id_new.608777141%3Apage_id.412510262457247%3Asrc.22%3Astory_location.6%3Astory_attachment_style.share%3Afilter.GroupStoriesByActivityEntQuery%3Atds_flgs.3%3Aott.AX_Y92KJ5Iont7jy%3Apage_insights.%7B%22412510262457247%22%3A%7B%22page_id%22%3A412510262457247%2C%22page_id_type%22%3A%22group%22%2C%22actor_id%22%3A608777141%2C%22dm%22%3A%7B%22isShare%22%3A1%2C%22originalPostOwnerID%22%3A0%7D%2C%22psn%22%3A%22EntGroupMallPostCreationStory%22%2C%22post_context%22%3A%7B%22object_fbtype%22%3A657%2C%22publish_time%22%3A1603449012%2C%22story_name%22%3A%22EntGroupMallPostCreationStory%22%2C%22story_fbid%22%3A%5B1225206621187603%5D%7D%2C%22role%22%3A1%2C%22sl%22%3A6%7D%7D&amp;__tn__=%2As-R"><span class="cr cs">#riskminds</span></a></p>
<p></span>
</p>
<p><a href="https://buff.ly/3d8MTrz"><img decoding="async" title="Health Medical Pharma" alt="Health Medical Pharma" src="https://i.ytimg.com/vi/inW8KlAv_wg/maxresdefault.jpg" width="112" height="112" class="l" role="presentation"></a> </p>
<p><a href="https://buff.ly/3d8MTrz">Covid-19: How are CROs currently navigating through this difficult time?</a></p>
<p><a href="https://www.facebook.com/groups/412510262457247/permalink/1225206621187603">Присоеденяйтесь к официальной группе ИСАР в Facebook</a> </p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>1615 participants already registered! See you at the RAW2020</title>
		<link>https://risk-academy.ru/1615-participants-already-registered-see-you-at-the-raw2020/</link>
		
		<dc:creator><![CDATA[riskacademy]]></dc:creator>
		<pubDate>Fri, 23 Oct 2020 07:10:57 +0000</pubDate>
				<category><![CDATA[Официальная группа ИСАР]]></category>
		<category><![CDATA[Health Medical Pharma]]></category>
		<category><![CDATA[Law Crime]]></category>
		<category><![CDATA[In Norway]]></category>
		<category><![CDATA[Deposition]]></category>
		<guid isPermaLink="false">https://risk-academy.ru/1615-participants-already-registered-see-you-at-the-raw2020/</guid>

					<description><![CDATA[1615 participants already registered! See you at the RAW2020 https://2020.riskawarenessweek.com/?utm_campaign=10-23-20&#8212;1615-participan&#38;utm_source=Message&#38;utm_medium=Facebook Присоеденяйтесь к официальной группе ИСАР в Facebook]]></description>
										<content:encoded><![CDATA[<p><span></p>
<p>1615 participants already registered! See you at the RAW2020 <a href="https://lm.facebook.com/l.php?u=https%3A%2F%2F2020.riskawarenessweek.com%2F%3Futm_campaign%3D10-23-20---1615-participan%26utm_source%3DMessage%26utm_medium%3DFacebook&amp;h=AT0Sv1HYbsXW-jn28ydXBmW6FSYvEDXUXRdPk5mDcLug1pd9FSeh_BW6GO2NHYKxtDp64Zd_poyKbuItKGRD3Zr0VhSoDA6JNWfxJcTxjA-FuDrKRoYd0aftLb-e3d9GtdUOeWmV8ojFlnCj43bJsShGAwViLLO-NWXVfHbxRFK213bgjB12h_m739gmKpBx1f0Nkp78Sq3xURckiMn3nOjZMgwJM2TZua3-ty8KTOZc85D40bxSSGAw2Gpk3HxxhYNua9RxfPo2oxU4gxTEJ1KWdGarsJ-RVXGgaRW8fbOByRQbMnmOxv2MIYjiOr6zgzfRgTBEhRGhdA3Pl4jXXsyIxR3Ia-zXvmtpXGfWgTdmTocxbsLG67FQLehURDoJ4Q0Szaa9laWgxLuuItnRwOSnG_9Uffo96FZKfveIGA_XdvSjBSGn7TinUzb04oBDAls_PsEAKvkIwXeiv91bJLwtYUah-nxVA8KUcYBPLFwogJEpPQ1py0YqJ4Qc9CvG5KW62McIH4Kwq_siBmqxaeWQ08ph6JWvFp3VSZU2xadEjNTqmEv02kPYE1eslEIOFijmeJHnitX_8EV3l81VF28nvUD8p6tEznSPwqamZYxssoK7j8ixiilLaw8oVSEUHEudMBOQaTe8Pe4NmHk15FCKpV-cT4Nxa9MqLCW8IRyAWcPIVvTB_Q2pGPLuCBtdFgXkWzkyar_4ax2V4VlLzTzN9zpAP9244iCTjJo3tIFyKtqf-pco92jtbFDU8goTfUzxNZd1alzrx-haAC-0GVMVhDQViH1xlmB_k_bTjkXBz4IusEEnScc3xwhVrgzPB-vNy5tMgqA5wZ1kIl0JFjOiWgW4BI2HfK-QonwNvc_ulVPilU9yavrh_o8mGZh2yPdAas-6HTUM2jTDI3xqFknu4FMZQkZsaZkyQXng90S8-qhXerPKSU2CErqF5aVaCscqrDoa7yWIVNV0xtRf0-0gtv8ArUpyy6VWKr8tcqlZezJ_qfK48WIyN-vI18guuvqF_YHyFWfB8DWJuabAnjNeG3BEFd0gQHeez2cGFmPSShocb8mKv8UYeY1cw4QwezcAqs-fZP24P4MF0Upp0tP7" target="_blank" rel="noopener noreferrer"><span>https://</span><wbr></wbr><span class="word_break"></span><span>2020.riskawarene</span><wbr></wbr><span class="word_break"></span><span>ssweek.com/</span><wbr></wbr><span class="word_break"></span><span>?utm_campaign=10</span><wbr></wbr><span class="word_break"></span><span>-23-20&#8212;1615-p</span><wbr></wbr><span class="word_break"></span><span>articipan&amp;utm_s</span><wbr></wbr><span class="word_break"></span><span>ource=Message&amp;u</span><wbr></wbr><span class="word_break"></span><span>tm_medium=Faceb</span><wbr></wbr><span class="word_break"></span>ook</a></p>
<p></span>
</p>
<p> <img decoding="async" title="Health Medical Pharma" src="https://scontent-dfw5-1.xx.fbcdn.net/v/t1.0-0/cp0/e15/q65/s240x240/122489072_10157145320937142_4070699905119230510_n.jpg?_nc_cat=110&#038;ccb=2&#038;_nc_sid=ca434c&#038;_nc_ohc=0uCDTPLnf0QAX9HBZe_&#038;_nc_ht=scontent-dfw5-1.xx&#038;tp=9&#038;oh=26a668f174e21436b7edda6846454df4&#038;oe=5FB83FE9" width="238" height="200" class="l" alt="Image may contain: text that says 'RISK AWARENESS WEEK e n Bernoulli distribution describes whether an event occurs (=1) or doesn't (=0). The Bernoulli distribution is a basic risk modelling tool that allows you to build up realistic models when used with logical functions like IF, AND, OR.'"></p>
<p><a href="https://www.facebook.com/groups/412510262457247/permalink/1225090881199177">Присоеденяйтесь к официальной группе ИСАР в Facebook</a> </p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
